Michl, Martin (Department of Ophthalmology, Medical University of Vienna), Mitsch, Christoph (Department of Ophthalmology, Medical University of Vienna)
Target aging where it starts: in your cells
Recent Developments: Initiated Phase 3 trials for orforglipron, aiming to provide an oral alternative to injectable GLP-1 drugs
Primary care guidelines were updated to include meal replacement shakes and fiber supplements alongside GLP-1 prescriptions
If you wait too long to engage your provider, you may have to go all the way back to your initial starting dose. If your dose is not currently available Sometimes, manufacturer shortages force a treatment gap beyond your control
Discuss strategies to manage weight loss and facial changes